Prolonged Ex vivo expansion and differentiation of naïve murine CD43− B splenocytes |
| |
Authors: | Kenny Zambrano Valérie Jérôme Ruth Freitag Rainer Buchholz Hans‐Martin Jäck Wolfgang Schuh |
| |
Affiliation: | 1. Institute of Bioprocess Engineering, Friedrich‐Alexander‐University Erlangen Nürnberg, Erlangen, Germany;2. Chair for Process Biotechnology, University of Bayreuth, Bayreuth, Germany;3. Division Molecular Immunology, Dept. of Internal Medicine III, Nikolaus Fiebiger Zentrum, Friedrich‐Alexander‐University Erlangen‐Nürnberg, Erlangen, Germany |
| |
Abstract: | Ex vivo expansion of naive primary B cells is still a challenge, yet would open new possibilities for in vitro studies of the immune response or the production of monoclonal antibodies. In our hands, unstimulated murine B cells did not expand in significant numbers, while culture viability decreased rapidly within a few days. Activation mimicking in vivo stimulation through either T cell‐independent or T‐cell dependent signaling, led to several division cycles, albeit accompanied by irreversible differentiation. By co‐culturing B cells under moderate hypothermia (30°C) on live feeder fibroblasts expressing recombinant CD40 ligand (CD154) and by repeatedly transferring cultured B cells to new feeder cell cultures, we could extend the growth of primary mouse B cells compared to cultures maintained at 37°C. B cells under these conditions showed an activated phenotype as shown by the presence of AID and IRF4, two factors required for IgH class switch recombination in antigen‐activated B cells. In contrast to cells cultured at 37°C, B cells under hyperthermia did surprisingly not differentiate into Blimp‐1 expressing plasmablasts. Thus, the repeated batch process under hyperthermic conditions represents a first step towards the development of a continuous cultivation system for the expansion of primary B cells. © 2016 American Institute of Chemical Engineers Biotechnol. Prog., 32:978–989, 2016 |
| |
Keywords: | CD40 ligand feeder cells in vitro B cell expansion MACS B lymphocytes antibodies |
|
|